story of the week
Repurposed Antiviral Drugs for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
N. Engl. J. Med 2020 Dec 02;[EPub Ahead of Print], H Pan, R Peto, AM Henao-Restrepo, MP Preziosi, V Sathiyamoorthy, Q Abdool Karim, MM Alejandria, C Hernández García, MP Kieny, R Malekzadeh, S Murthy, KS Reddy, M Roses Periago, P Abi Hanna, F Ader, AM Al-Bader, A Alhasawi, E Allum, A Alotaibi, CA Alvarez-Moreno, S Appadoo, A Asiri, P Aukrust, A Barratt-Due, S Bellani, M Branca, HBC Cappel-Porter, N Cerrato, TS Chow, N Como, J Eustace, PJ García, S Godbole, E Gotuzzo, L Griskevicius, R Hamra, M Hassan, M Hassany, D Hutton, I Irmansyah, L Jancoriene, J Kirwan, S Kumar, P Lennon, G Lopardo, P Lydon, N Magrini, T Maguire, S Manevska, O Manuel, S McGinty, MT Medina, ML Mesa Rubio, MC Miranda-Montoya, J Nel, EP Nunes, M Perola, A Portolés, MR Rasmin, A Raza, H Rees, PPS Reges, CA Rogers, K Salami, MI Salvadori, N Sinani, JAC Sterne, M Stevanovikj, E Tacconelli, KAO Tikkinen, S Trelle, H Zaid, JA Røttingen, S SwaminathanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.